by Other patients can die as a result of plans created by the Trump government to reduce billions of dollars from the National Cancer Institute (NCI), warned the veterans.
Almost 2.7 billion USD would be dismantled by the agency, the world’s largest sponsor of cancer research – a decline of 37.2% compared to the previous year – as part of a budget proposal for 2026 to reduce employees and financing.
“These cuts are absolutely intestinal laws,” Erin Lavik, former deputy director and Chief Technology Officer, told the Guardian at the Department of Cancer Prevention.
Lavik was released in February together with a swath of probation workers at the institute. Administrative leave in response to a judge’s decision to stop the shots in March; And then ended again in April.
“We don’t make things more efficient or better,” she said. “What is left is a kind of and non -inconsistent iterative work, and we cut the entire potential for transformative science.”
Related: Nih scientists go to the public to denounce Trump’s profound cuts in health research
The Cancer Action Network of the American Cancer Society pointed out that the proposed cuts “in our ability to reduce death and suffering” are dramatically due to, and that cancer is expected to kill more than 618,000 Americans this year.
Julie Nickson, Vice President of Federal Advocacy and Coalitions, said: “This would not only be a blow to science, but a blow to families, communities and our economy. Every day the fight against cancer and with more than 2 million Americans, which are expected to be expected in this terrible illness in 2025.
Jennifer R. Brown, Secretary of the American Society of Hematology and director of the Chronic Lymphocytic Leukemia Center (CLL) of the Hematological Malignities Department at the Dana-Farber Cancer, told The Guardian that it could not be easily started that he cannot be easily restarted.
“What the public needs to know is that science, which may not sound so obvious or that they don’t know so much, really drives our cancer treatments and our cancer. If we cut it, we will lose them,” said Brown.
Cancer research, which is historically financed by the National Institutes of Health (NIH) in which the NCI is housed, “is basic science that finds out what is aimed at in the cancer cell,” she said. “Then a medication can be developed that may come from an academic, it can come from a pharmaceutical company, but the studies are then also carried out by academics and pharmaceuticals in cooperation and academics who are financed by NIH who do the footwork to find out how the medication works in patients.
“Pharmaceutical companies take the medication to the finish line. If we do not have this basic research, we will not be able to identify new goals, and that means that we have no new therapies and ultimately can die more patients.”
Brown sees a direct connection between the academic research and cancer medication financed by NIH for chronic lymphology leukemia that helped the patient longer.
“People who had died in a few months lived with the first version of this drug for years,” she said.
In the past few months, hundreds of employees from the NCI have been terminated, including dozens of communication employees. “Our website cancer.gov is used worldwide and is the basic truth for cancer information,” said a communication employee at the institute, who asked to stay anonymous. “Science is only ended when it has communicated.”
Between February 28 and April 8, the NCI subsidies of more than 180 million US dollars were canceled by the Trump administration.
Nih refused to comment and shifted to comments on the cuts of the budget proposal to the Office for Management and Budget, which did not respond to inquiries about comments.
Nih did not comment on how many employees of the agency remain after several rounds of cuts and layoffs.
Related: Trump’s security research cuts increase the risks in the workplace, warn federal workers
Lavik said the cuts are likely to threaten large research programs such as the National Community Oncology Research Program, which covers community hospitals in the USA and ensure that patients have access to clinical studies, cancer care, prevention and examinations.
“I am deeply concerned about the future of these really important programs for clinical studies that are really difficult to rebuild when they stop them,” she said. “There are great screening attempts in the prevention program and you have large data records. We have worked very hard on guidelines to make these data records more accessible and available to the research community. And we are all gone.”
According to Lavik, the scientists in the entire science financing of the federal scientists consider to consider science and younger scientists to enter younger scientists as students, graduates and postdocs as students, as students, graduate researchers and postdocs.
“Things that are transformative are fundamentally with high risk and high upbringing,” she said. “We start moving to the clinic, and this leads to the new types of treatments that not only help a little, but also the face of the treatment of patients how we prevent cancer, as we treat other diseases.
“You have to be ready to do many, many things that don’t work. There are so many options that we should be more efficient in relation to what we do.
